Alacizumab pegol
From The Right Wiki
Jump to navigationJump to search
Pharmaceutical drugTemplate:SHORTDESC:Pharmaceutical drug
Pharmaceutical compoundTemplate:SHORTDESC:Pharmaceutical compound
Monoclonal antibody | |
---|---|
Type | F(ab')2 fragment |
Source | Humanized (from mouse) |
Target | VEGFR2 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
☒NcheckY (what is this?) (verify) |
Alacizumab pegol is an antineoplastic agent. Chemically, it is a pegylated F(ab')2 fragment of a monoclonal antibody.[1]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | |||||||||
---|---|---|---|---|---|---|---|---|---|
Bone |
| ||||||||
Musculoskeletal |
| ||||||||
Circulatory |
| ||||||||
Neurologic |
| ||||||||
Angiogenesis inhibitor |
| ||||||||
Growth factor |
| ||||||||
|
Stub icon | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
Stub icon | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://rightwiki.org/index.php?title=Alacizumab_pegol&oldid=4809998"
Hidden categories:
- Articles with short description
- Short description with empty Wikidata description
- Drugs not assigned an ATC code
- Articles with changed CASNo identifier
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- All stub articles
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs